1Department of Hematology-Oncology and Cancer Biology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA.
2Center for Advanced Biotechnology and Medicine and Susan Lehman Cullman Laboratory for Cancer Research, Ernest Mario School of Pharmacy, Rutgers, State University of New Jersey, Piscataway, NJ 08854, USA.
↵†To whom correspondence should be addressed. E-mail: vboussio{at}bidmc.harvard.edu
↵* These authors contributed equally to this work.
See allHide authors and affiliations
Science Signaling 26 Jun 2012: Vol. 5, Issue 230, pp. ra46 DOI: 10.1126/scisignal.2002796
Nikolaos Patsoukis
1Department of Hematology-Oncology and Cancer Biology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA.
2Center for Advanced Biotechnology and Medicine and Susan Lehman Cullman Laboratory for Cancer Research, Ernest Mario School of Pharmacy, Rutgers, State University of New Jersey, Piscataway, NJ 08854, USA.